Drug factory · FDA FEI 3007221763
CSPC-NBP Pharmaceutical Co., Ltd.
No.88 Yangzi Road, Economic and Technological Development Zone, Shijiazhuang, China
Problems found, fixed voluntarily at FDA's last inspection, Apr 12, 2024.
Voluntary Action Indicated: inspectors found problems, but not serious enough for FDA to take action. The company is expected to fix them.
1 drug inspection on record since 2024: 0 with no problems, 1 with problems fixed voluntarily, 0 with FDA action.
What it does, for whom
| Drug | Role | For | NDC |
|---|---|---|---|
| Benzonatate | Makes it | TAGI Pharma, Inc. | 51224-001, 51224-010 |
FDA inspection history
| Ended | Result | Program | Problems noted |
|---|---|---|---|
| Apr 12, 2024 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
Registered with FDA for: manufacture.